ANIX Gross Margin

The Gross Margin of Anixa Biosciences Inc (ANIX) is 97.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ANIX Gross Margin - Historical Value

Date	Value
2024-10-31	97.00%

ANIX Gross Margin - Peers Comparison

Ticker	Name	Value
SCPS	Scopus Biopharma Inc	7775.20%
SLNO	Soleno Therapeutics Inc	40.98%
WLLW.TO	Willow Biosciences Inc	-809.99%
CLGN	Collplant Biotechnologies Ltd	-160.00%
EVAX	Evaxion A/S	7775.20%
LUMO	Lumos Pharma Inc	7775.20%
ABBV	Abbvie Inc	69.99%
ADXS	Ayala Pharmaceuticals Inc	-
CYCN	Cyclerion Therapeutics Inc	7775.20%
950200.KQ	Psomagen Inc	23.13%
ATNF	180 Life Sciences Corp	7775.20%
ATNM	Actinium Pharmaceuticals Inc	100.00%
BCLI	Brainstorm Cell Therapeutics Inc	7775.20%
CRVS	Corvus Pharmaceuticals Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
ALRN	Aileron Therapeutics Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
ARAV	Aravive Inc	7775.20%
AYLA	Old Ayala Inc	-
MRNA	Moderna Inc	70.06%
MRZM	Marizyme Inc	70.87%
ONC.TO	Oncolytics Biotech Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
950160.KQ	Kolon TissueGene Inc	11.72%
GILD	Gilead Sciences Inc	78.26%
TCON	TRACON Pharmaceuticals Inc	7775.20%
AIKI	Aikido Pharma Inc	100.00%
APRE	Aprea Therapeutics Inc	7775.20%
PDSB	PDS Biotechnology Corp	7775.20%
DFFN	Diffusion Pharmaceuticals Inc	100.00%
DYAI	Dyadic International Inc	65.82%
INMB	INmune Bio Inc	7775.20%
LPTX	Leap Therapeutics Inc	7775.20%
SLS	Sellas Life Sciences Group Inc	90.00%
AMGN	Amgen Inc	68.71%